M. Jacob Chacko's most recent trade in ORIC Pharmaceuticals Inc was a trade of 675,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 675,000 | 675,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 112,500 | 112,500 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 83,666 | 615,085 | - | 0 | Common Stock | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 15 Dec 2025 | 33,374 | 581,711 | - | 9.1 | 302,368 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 28,333 | 28,334 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 22,000 | 0 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.32 per share. | 06 Oct 2025 | 37,461 | 531,419 | - | 12.3 | 461,520 | Common Stock |
| ORIC Pharma Inc | Chacko Jacob M. | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.05 per share. | 30 Sep 2025 | 53,001 | 568,880 | - | 12.1 | 638,805 | Common Stock |
| ORIC Pharma Inc | M. Chacko Jacob | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 30 Sep 2025 | 34,538 | 621,881 | - | 12.0 | 414,750 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 10.80 per share. | 22 Sep 2025 | 125,000 | 656,419 | - | 10.8 | 1,349,938 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 100,000 | 100,000 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 67,000 | 803,308 | - | 0 | Common Stock | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 28,333 | 56,667 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 8.28 per share. | 15 Dec 2024 | 24,660 | 778,648 | - | 8.3 | 204,214 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 22,000 | 22,000 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 16,667 | 0 | - | - | Restricted Stock Unit | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 06 Mar 2024 | 40,000 | 728,544 | - | 16.2 | 648,380 | Common Stock |
| ORIC Pharma Inc | M. Chacko Jacob | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.29 per share. | 06 Feb 2024 | 26,042 | 768,544 | - | 12.3 | 320,186 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 06 Feb 2024 | 13,958 | 794,586 | - | 12.1 | 169,160 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 510,000 | 510,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | M. Jacob Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 85,000 | 85,000 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Chacko Jacob M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 38,667 | 823,083 | - | 0 | Common Stock | |
| ORIC Pharma Inc | M. Jacob Chacko | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 22,000 | 44,000 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob Chacko M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 16,667 | 16,667 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.58 per share. | 15 Dec 2023 | 14,539 | 808,544 | - | 8.6 | 124,813 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 10 Jul 2023 | 10,508 | 785,808 | - | 8.0 | 84,212 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 10 Jul 2023 | 5,156 | 780,652 | - | 8.0 | 41,287 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 05 Jul 2023 | 4,336 | 796,316 | - | 8.0 | 34,711 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.03 per share. | 26 Jun 2023 | 20,000 | 800,652 | - | 8.0 | 160,562 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 21 Apr 2023 | 5,000 | 0 | - | 20.1 | 100,270 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 5,000 | 32,500 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.41 per share. | 21 Apr 2023 | 5,000 | 5,000 | - | 9.4 | 47,050 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 66,000 | 66,000 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jul 2022 | 437,500 | 0 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 437,500 | 437,500 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jul 2022 | 300,000 | 0 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 280,000 | 280,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jul 2022 | 280,000 | 0 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 11 May 2022 | 304,574 | 657,226 | - | 2.9 | 883,569 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 11 May 2022 | 76,072 | 802,652 | - | 2.8 | 214,561 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 11 May 2022 | 69,354 | 726,580 | - | 2.7 | 190,467 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 23 Mar 2022 | 257,127 | 259,779 | - | 5.0 | 1,280,878 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.54 per share. | 23 Mar 2022 | 50,000 | 352,652 | - | 4.5 | 227,170 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.03 per share. | 23 Mar 2022 | 42,873 | 302,652 | - | 5.0 | 215,660 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 14 Sep 2021 | 4,420 | 6,388 | - | 25.0 | 110,706 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 14 Sep 2021 | 3,736 | 2,652 | - | 25.1 | 93,629 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 10 Sep 2021 | 2,942 | 13,609 | - | 25.1 | 73,783 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 10 Sep 2021 | 2,801 | 10,808 | - | 25.0 | 70,089 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 07 Sep 2021 | 5,981 | 16,751 | - | 25.1 | 150,173 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 07 Sep 2021 | 200 | 16,551 | - | 25.0 | 5,007 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.20 per share. | 20 May 2021 | 4,790 | 23,144 | - | 25.2 | 120,688 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 20 May 2021 | 2,468 | 27,934 | - | 25.1 | 61,864 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 20 May 2021 | 12 | 23,132 | - | 25 | 300 | Common Stock |
| 4D Molecular Therapeutics Inc | Jacob M. Chacko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.36 per share. | 14 May 2021 | 13,896 | 44,284 | - | 25.4 | 352,465 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.37 per share. | 14 May 2021 | 11,132 | 30,602 | - | 25.4 | 282,428 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 14 May 2021 | 2,550 | 41,734 | - | 25.1 | 63,884 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.03 per share. | 14 May 2021 | 200 | 30,402 | - | 26.0 | 5,206 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 11 May 2021 | 1,090 | 59,310 | - | 25.2 | 27,490 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 11 May 2021 | 730 | 58,180 | - | 25.0 | 18,281 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 11 May 2021 | 400 | 58,910 | - | 25.0 | 10,010 | Common Stock |
| ORIC Pharma Inc | Jacob M. Chacko | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.09 per share. | 01 Apr 2021 | 800 | 61,700 | - | 25.1 | 20,070 | Common Stock |